Let’s start working together, today. You can contact us!
NBLST
Latest Updates
February 07, 2026
A Disruptive Breakthrough: Intranasal Delivery of Nanobodies Opens a New Pathway for Depression Treatment
A recent international collaborative research team published a landmark study in the top-tier journal Nature Communications. For the first time, they successfully developed a nanobody (Nb20)...
February 07, 2026
January 30, 2026
In-depth Analysis of PD-L1 Target: Why It Has Become a "Star Target" in Cancer Immunotherapy?
In the golden track of cancer immunotherapy, immunotherapy targeting PD-1 (Programmed Death Receptor 1) has become a classic paradigm, but its single-target strategy faces bottlenecks in clinical...
January 30, 2026
January 23, 2026
Dual-Action Strategy: Novel Bispecific Nanobodies Achieve Dual Defense through Virus "Neutralization" and "Physical Trapping"
Despite advances in vaccines and antiviral drugs, the prevention and transmission of respiratory viral infections remain major global challenges. A significant limitation of existing approaches is...
January 23, 2026
Support is Offline
Today is our off day. We are taking some rest and will come back stronger tomorrow
Official support hours
Monday To Friday
From 9:00AM To 6:00PM
Address
Building A, 15th Floor, WHIIID Headquarters, No. 666 Gaoxin Avenue, East Lake New Technology Development Zone, Wuhan City, P.R of China
Call Us now
Email & Social